Document Detail


Heparin levels to guide thromboembolism prophylaxis during pregnancy.
MedLine Citation:
PMID:  8610778     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Our purpose was to determine the dose of heparin required in pregnant women to achieve the same heparin levels as standard doses of 5000 units given subcutaneously every 12 hours in the nonpregnant population. STUDY DESIGN: Fourteen pregnant women placed on heparin prophylaxis for a history of thromboembolism had blood drawn for 64 anti-Xa level determinations in the second and third trimesters. Heparin doses were adjusted in an attempt to achieve a midinterval or peak level of 0.05 to 0.25 U/ml, which corresponds to the range seen in nonpregnant patients given standard doses of 5000 units subcutaneously every 12 hours. RESULTS: A standard heparin dose of 5000 units given subcutaneously every 12 hours was inadequate to achieve the desired range in this pregnant population. In five of nine second-trimester pregnancies 7500 units given subcutaneously every 12 hours was inadequate to attain this range. In six of 13 third-trimester pregnancies, > 10,000 units subcutaneously every 12 hours was needed. CONCLUSIONS: Heparin requirements may increase and are highly variable in patients during pregnancy. Until appropriate clinical outcomes trials can determine optimal dosing, measuring anti-Xa activity may be useful to guide therapy.
Authors:
L A Barbour; J M Smith; R A Marlar
Related Documents :
12890918 - Usefulness of a second temporary vena cava filter for preventing acute pulmonary thromb...
9207398 - Activated protein c resistance can be associated with recurrent fetal loss.
15383488 - Use of antithrombotic agents during pregnancy: the seventh accp conference on antithrom...
22723328 - Association and predictive accuracy of high tsh serum levels in first trimester and adv...
25368718 - Peri-partum cardiomyopathy in a pregnant woman at term revealed by acute pulmonary edem...
8403618 - Gonadotropin-releasing hormone and its analogues: applications in gynecology.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  173     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1995 Dec 
Date Detail:
Created Date:  1996-05-24     Completed Date:  1996-05-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1869-73     Citation Subset:  AIM; IM    
Affiliation:
Department of Internal Medicine, University of Colorado Health Sciences Center, Denver 80262, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies / blood
Drug Administration Schedule
Factor Xa / analysis
Female
Heparin / administration & dosage*
Humans
Injections, Subcutaneous
Partial Thromboplastin Time
Pregnancy
Pregnancy Complications, Cardiovascular / prevention & control*
Thromboembolism / prevention & control*
Chemical
Reg. No./Substance:
0/Antibodies; 9005-49-6/Heparin; EC 3.4.21.6/Factor Xa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Monitored outpatient management of mild gestational hypertension remote from term in teenage pregnan...
Next Document:  Low-dose versus high-dose oxytocin augmentation of labor--a randomized trial.